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Gastrointestinal stromal tumors (GIST) are the most frequent sarcomas in the gastrointestinal tract. They affect 
all segments of the digestive tract. The incidental occurrence of GIST and other primary tumors has not been 
well described in literature. We describe a case of a 73 year old patient who underwent surgery for gastric GIST 
with an incidental pathologic diagnosis of a gastric neuroendocrine tumor. The occasional finding of this 
association underlines the importance of a carefully pathological diagnosis for its identification. In literature 
there is no evidence of concomitant neuroendocrine tumor and gastrointestinal stromal tumor (GIST) at gastric 
site. 
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1. Introduction  
• Gastrointestinal stromal tumors (GIST) are the most common mesenchymal neoplasms of the 
gastrointestinal tract accounting for 80% of gastrointestinal sarcomas [1],with a malignant potential  1 à 
3 %.  
----------------------------------------------------------------------- 
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• However, uncommonly they can be associated with synchronous tumors of different histogenesis, they 
are almost always discovered incidentally as during surgery or staging exams of the primary disease 
2. Case presentation 
• We describe a case of a 73 year old male patient, with history of many episodes of melena and anemia 
• Upper gastrointestinal endoscopy revealed a nodular lesion sub mucosal in the antro-fundial junction 
measuring 25x15 mm another calcification was seen in the gastric fundus measuring 3cm 
• Multiple tissue biopsies histological returning negative .Subsequently all the necessary staging exams, 
including a total body Computed Tomography (CT) were performed. The CT did show a  lesion in the 
small gastric curvature measuring 14mm  and another lesion in pyloro-duodenal level measuring 16mm 
(Figure 1) 
 
Figure 1: Contrast-enhanced computed tomography (CT) of upper abdomeshowed a lesion in small gastric 
curvature 
Pathological examination 
• Wedge resection of gastric tumor was performed (3 tumors founded) 
• For the first nodule, histology revealed a neuroendocrine tumor, grade 1, the surgical margins were 
considered free of infiltration, and the final staging was pT1 pNx . Immmunohistochemistry showed 
strong staining for Synaptophysin , chromogranin confirming the neuroendocrine nature, The 
proliferate index Ki 67 was less than 5% (Figure 2) 
• For the other nodules Stomach showed a firm sub mucosal tumor measuring 5.5 cm and 3.5cm, 
Immmunohistochemistry demonstrated positive staining for CD117  and Dog 1. Tumor cells were 
negative for AML and S100. Features were consistent with benign GIST (Figure 3) 




Figure 2: Histology of nodule showing nests of neuroendocrine tumor 
 
Figure 3: Histology of others nodules showing nests of GIST 
3. Discussion 
• Gastrointestinal stromal tumors (GIST) are the most frequent sarcomas in the gastrointestinal tract. 
They affect all segments of the digestive tract. They develop from the interstitial cells of Cajal , with a 
preferred gastric localization (about 60-70 % in the stomach and 20–30% in the intestine), with smaller 
percentages these lesions have been described in other regions such as the large intestine, rectum, and 
omentum [2].  
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• The median age of onset is 60–69 years and the symptoms are usually non-specific such as tiredness, 
abdominal discomfort and gastro-intestinal bleeding [3]. 
• KIT and PDGFRA activating mutations are the oncogenic mechanisms in most sporadic and inherited 
GISTs [4]. 
• Positivity for the CD117 is the key feature of GIST, but CD34 and nestin are other commonly 
expressed but less GIST-specific antigens. Moreover, these tumors can be positive for smooth muscle 
markers and generally negative for desmine. S-100 protein expression is rare and glial fibrillary acidic 
protein is not present. Keratin 18 and Keratin 8 are occasionally expressed. 
• GISTs are unique in 95% of cases. Multiple locations are very rare [5] with an average incidence of 10 
to 35% described in the literature[6-11] 
• The synchronous existence of two different tumors in the gastrointestinal tract is uncommon and an 
unusual event. with few published studies dealing with this phenomenon Most cases involve 
adenocarcinomas, lymphomas, carcinoids, or leiomyosarcomas of the stomach [12],coexistence of 
gastric GIST with neuroendocrine tumor is extremely rare 
• Only 3 cases of concomitant gastric carcinoid and GIST have been reported in the literature [13,14] 
• CRILLO reported , 4 of the 300 observed cases (1.3%) showed an unusual association with rare no 
epithelial neoplasms,  1 case of gastric carcinoid and gastrointestinal stromal tumor (GIST) [14]. 
• Ramneet Kaur and his colleagues report two cases of gastric GIST with synchronous tumors ,the first case 
is of a patient who was suspected with GIST of stomach and was incidentally found to have an associated 
duodenal neuroendocrine neoplasm [15]. 
• The etiology of synchronous occurrence of GISTs with histological unrelated tumors still remains 
unclear. Some authors have postulated that they may share common carcinogenic pathways or genetic 
mutations with proliferation of different cell lines [16]. 
• Awareness of occurrence and pattern of synchronous GIST and other neoplasms is important for both 
histopathologists and surgeons 
4. Conclusion 
The synchronous presence of GIST and other tumors is rare and unusual, generally revealed in perioperative and 
anatomo-pathology, whose etiologies remain obscure requiring molecular and genetic investigations to illustrate 
the mechanisms of carcinogenesis 
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